People who took aromatase inhibitors to prevent breast cancer recurrence for at least 5 years had a higher risk for developing high blood pressure, high cholesterol or diabetes, according to research presented at @AACR Annual Meeting. Learn more: https://t.co/RsvgQubnxu #AACR26 https://t.co/qcCPoQXqto